Leah Sabin shares her STEM journey, from studying viruses to advancing genetic medicine, and the potential of genetic therapies.

Researchers have identified the CH25H enzyme in cancerous lymphatic cells as a key regulator of immune cell activity.

CN Bio enhances hepatotoxicity testing to improve drug safety, reducing the risk of costly clinical trial failures.

Scientists discover novel enhancers linked to neuropsychiatric diseases, paving the way for new drug discovery opportunities.

Explore how Capgemini's innovative approach is enhancing the bioeconomy through generative AI in protein engineering.